Alto Neuroscience (ANRO) Change in Accured Expenses (2023 - 2026)
Alto Neuroscience (ANRO) recorded Change in Accured Expenses of $1.21 million in Q2 2026, up 161.8% from $463,000 a year earlier.
Powered by 
Analysis
Alto Neuroscience (ANRO) Change in Accured Expenses (2023 - 2026) Analysis & Trends
On a TTM basis, Alto Neuroscience's Change in Accured Expenses came in at $1.41 million as of Jun 30, 2026; for FY2025, it was -$289,000.
- Across earlier years, Change in Accured Expenses came in at $4.01 million in FY2024 and -$357,000 in FY2023.
- Quarterly Change in Accured Expenses has ranged from -$2.7 million in Q1 2025 to $1.74 million in Q4 2025 over the past five years.
- On a year-over-year basis, Change in Accured Expenses rose in three of the last five quarters, with growth averaging 71.4%.
- Per Business Quant, the preceding three quarters came in at -$1.75 million (Q1 2026), $1.74 million (Q4 2025) and $208,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Alto Neuroscience | 870.68 Mn | 870.68 Mn | - | 1.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.21 Mn |
| Mar 31, 2026 | -1.75 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | 208,000.00 |
| Jun 30, 2025 | 463,000.00 |
| Mar 31, 2025 | -2.70 Mn |
| Dec 31, 2024 | 411,000.00 |
| Sep 30, 2024 | 1.63 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Mar 31, 2024 | 406,000.00 |
| Dec 31, 2023 | -500,000.00 |
| Sep 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | -1.29 Mn |
| Mar 31, 2023 | 174,000.00 |
API Access
Alto Neuroscience Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ANRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "ANRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ANRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();